Breast One Stop Symptomatic Insourcing | Gateshead Health NHS Trust Tender

Section two: ObjectSection II: Object

two.1) Scope of the procurementII.1) Scope of the procurement

two.1.1) TitleII.1.1) Title

Breast One Stop Symptomatic Insourcing

Reference number

project_23273

two.1.2) Main CPV codeII.1.2) Main CPV code

• 85121200 – Medical specialist services

two.1.3) Type of contractII.1.3) Type of contract

Services

two.1.4) Short descriptionII.1.4) Short description

Provision of insourced symptomatic breast one‑stop diagnostic services delivered on Trust premises. The service will support breast cancer pathways through consultant‑led clinics, including diagnostic mammography, ultrasound and biopsy where clinically indicated, together with completion of all associated clinical documentation and reporting, in line with Trust policies and national standards.

Contract period:

The services are intended to commence in June 2026 and will continue until completion of the required activity or exhaustion of available funding. The arrangement may be extended, subject to funding availability and satisfactory performance, with the total duration not exceeding 18 months.

two.1.5) Estimated total valueII.1.5) Estimated total value

Value excluding VAT: £98,000

two.1.6) Information about lotsII.1.6) Information about lots

This contract is divided into lots: No

two.2) DescriptionII.2) Description

two.2.2) Additional CPV code(s)II.2.2) Additional CPV code(s)

• 85100000 – Health services

two.2.3) Place of performanceII.2.3) Place of performance

NUTS codes

• UK – United Kingdom

Main site or place of performance

Queen Elizabeth Hospital, Gateshead NE9 6SX

two.2.4) Description of the procurementII.2.4) Description of the procurement

Provision of insourced symptomatic breast one‑stop diagnostic services delivered on Trust premises. The service will support breast cancer pathways through consultant‑led clinics, including diagnostic mammography, ultrasound and biopsy where clinically indicated, together with completion of all associated clinical documentation and reporting, in line with Trust policies and national standards.

Contract period:

The services are intended to commence in June 2026 and will continue until completion of the required activity or exhaustion of available funding. The arrangement may be extended, subject to funding availability and satisfactory performance, with the total duration not exceeding 18 months.

two.2.5) Award criteriaII.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

two.2.7) Duration of the contract, framework agreement or dynamic purchasing systemII.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months18

This contract is subject to renewal

No

two.2.10) Information about variantsII.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about optionsII.2.11) Information about options

Options: No

Section three. Legal, economic, financial and technical informationSection III. Legal, economic, financial and technical information

three.1) Conditions for participationIII.1) Conditions for participation

three.1.1) Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registersIII.1.1) Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers

List and brief description of conditions

Selection criteria as detailed in tender documents

three.1.2) Economic and financial standingIII.1.2) Economic and financial standing

Selection criteria as stated in the procurement documents

three.1.3) Technical and professional abilityIII.1.3) Technical and professional ability

Selection criteria as stated in the procurement documents

Section four. ProcedureSection IV. Procedure

four.1) DescriptionIV.1) Description

four.1.1) Type of procedureIV.1.1) Type of procedure

Open procedure

four.1.8) Information about the Government Procurement Agreement (GPA)IV.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: No

four.2) Administrative informationIV.2) Administrative information

four.2.2) Time limit for receipt of tenders or requests to participateIV.2.2) Time limit for receipt of tenders or requests to participate

Date: 3 June 2026 Local time:5:00pm

four.2.4) Languages in which tenders or requests to participate may be submittedIV.2.4) Languages in which tenders or requests to participate may be submitted

English

four.2.7) Conditions for opening of tendersIV.2.7) Conditions for opening of tenders

Date

4 June 2026

Local time

9:00am

Section six. Complementary informationSection VI. Complementary information

six.1) Information about recurrenceVI.1) Information about recurrence

This is a recurrent procurement: No

six.3) Additional informationVI.3) Additional information

This is a Provider Selection Regime (PSR) Contract Notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.

The procurement documents are available electronically via the NHS Sourcing eTendering portal at: https://www.nhssourcing.co.uk

Bidders must register on the portal and access ITT reference: itt_6061 – Breast One Stop Symptomatic Insourcing. All bids must be submitted electronically via the portal by the stated deadline. No other method of submission will be accepted.

Bidders are required to submit the information and documentation specified in the Invitation to Tender (ITT), including completion of the Qualification and Technical envelopes and any supporting documentation requested.

Contract award criteria and assessment:

The contract will be awarded to the bidder offering the most advantageous tender in accordance with the Provider Selection Regime. Bids will be evaluated using the following criteria and weightings:

Quality and Innovation – 40%

Value (including pricing) – 30%

Integration and Sustainability – 10%

Access and Inequalities – 15%

Social Value – 5%

Evaluation will be conducted in stages, with an initial pass/fail assessment of mandatory and qualification requirements, followed by a scored evaluation of the technical criteria in accordance with the scoring methodology set out in the ITT.

six.4) Procedures for reviewVI.4) Procedures for review

six.4.1) Review bodyVI.4.1) Review body

PSR Review Panel

London

Country

United Kingdom